Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12027480 | 0.82 | — | — | |
| SCHEMBL12027481 | 0.71 | CES1 (0.31) | — | |
| SCHEMBL12028209 | 0.69 | — | — | |
| SCHEMBL9982961 | 0.68 | MMP2 (0.35) | ELANEALDH1A1LMNAMAPT | |
| SCHEMBL50526 | 0.67 | CES1 (0.35) | — | |
| SCHEMBL1421162 | 0.67 | MMP2 (0.37) | ALDH1A1LMNAMAPT | |
| SCHEMBL993128 | 0.67 | MMP2 (0.37) | ALDH1A1LMNAMAPT | |
| SCHEMBL1172970 | 0.67 | MMP2 (0.37) | ALDH1A1LMNAMAPT | |
| SCHEMBL12028322 | 0.67 | MAOA (0.38) | ELANELMNA | |
| SCHEMBL12028228 | 0.66 | ELANE (0.44) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210071004-A1 | NEAR-INFRARED ABSORBING DYE, OPTICAL FILTER, AND IMAGING DEVICE | AGC Inc. (JP) | 2021-03-11 | — | — | US | disclosed |
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| EP-2397475-A1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2011-12-21 | — | — | EP | disclosed |
| EP-2397475-A1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2011-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | DDT, NISCH, DBH | ELANE 2336/4885ALDH1A1 2561/4885LMNA 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.